As shown in the Fig. 4, the summarized proportion NASH patients with normal ALT in overall NASH patients was 19% (95%CI: 13–27%), which calculated by the random-effects model (P <  0.001, I2 = 85.0%). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.